Literature DB >> 17105960

Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study.

Gianfranco Natale1, Davide Cattano, Antonio Abramo, Francesco Forfori, Federica Fulceri, Francesco Fornai, Antonio Paparelli, Francesco Giunta.   

Abstract

The hyperactivation of glutamate receptors, especially those of the N-methyl-d-aspartate subtype (NMDA), can induce excess calcium entry into cells, leading to neuronal death. Since the anesthetic gas xenon behaves as an NMDA antagonist, the present article investigated, by distinct morphological approaches and after different times, the possible neuroprotectant effects of this gas in a model of neuronal damage induced by N-methyl-dl-aspartic acid (NMA) on rat arcuate nucleus. Rats were assigned to the following groups: controls; xenon exposure; NMA treatment; or xenon exposure + NMA treatment. Animals were placed in an experimental cage and after 10 min a mixture of xenon (or nitrogen) 70% and oxygen 30% was delivered. After 3 h, 1, 2, 5, or 7 days from gas exposure, rats were euthanized and the whole brain was removed and processed for either transmission electron microscopy or light microscopy. In the arcuate nucleus from NMA-treated animals only 40-60% of cell population survived in all times with several degenerating neurons giving the typical appearance of a "bull's eye." At ultrastructural level, chromatin margination, nuclear shrinkage, mitochondria with matrix dilution, dilated endoplasmic cisternae, and electrondense cytoplasm were detected. Xenon alone did not induce changes, but reduced of about 50% NMA-induced cell loss as well as degenerating neurons, with the maximal neuroprotection at 7 days. These results confirm that in the rat arcuate nucleus NMA can induce a severe neuronal damage that is already marked after 3 h. Xenon significantly reduced the neuronal damage at all times and can be then regarded as a promising neuroprotectant agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105960     DOI: 10.1196/annals.1369.063

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  [Neuroprotection by noble gases: New developments and insights].

Authors:  A V Fahlenkamp; R Rossaint; M Coburn
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

Review 2.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

3.  Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator.

Authors:  Hélène N David; Benoît Haelewyn; Jean-Jacques Risso; Jacques H Abraini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-11       Impact factor: 3.000

4.  Xenon anesthesia improves respiratory gas exchanges in morbidly obese patients.

Authors:  Antonio Abramo; Claudio Di Salvo; Francesca Foltran; Francesco Forfori; Marco Anselmino; Francesco Giunta
Journal:  J Obes       Date:  2010-03-02

5.  Application of medical gases in the field of neurobiology.

Authors:  Wenwu Liu; Nikan Khatibi; Aishwarya Sridharan; John H Zhang
Journal:  Med Gas Res       Date:  2011-06-27

6.  Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.

Authors:  Hélène N David; Benoît Haelewyn; Mickael Degoulet; Denis G Colomb; Jean-Jacques Risso; Jacques H Abraini
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

7.  Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult.

Authors:  Joline Goossens; Saïd Hachimi-Idrissi
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

8.  Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stress.

Authors:  J Lavaur; M Lemaire; J Pype; D Le Nogue; E C Hirsch; P P Michel
Journal:  Cell Death Discov       Date:  2016-05-16

9.  XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.

Authors:  Ecem Esencan; Simge Yuksel; Yusuf Berk Tosun; Alexander Robinot; Ihsan Solaroglu; John H Zhang
Journal:  Med Gas Res       Date:  2013-02-01

Review 10.  Inhaled Gases for Neuroprotection of Neonates: A Review.

Authors:  Youness Tolaymat; Sylvain Doré; Hudson W Griffin; Susana Shih; Mary E Edwards; Michael D Weiss
Journal:  Front Pediatr       Date:  2020-01-27       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.